News section dedicated to healthcare industries.
29.Feb.24 12:03 PM

Xenotransplantation Advance: Genetically Modified Pigs for Human Organ Transplants

Japanese researchers have produced three piglets cloned from a genetically modified pig, marking a significant step towards xenotransplantation, the transplantation of animal organs into humans. The original genetically modified pig was created by eGenesis, a U.S. biotechnology company, with 12 modified genes to prevent rejection in human recipients.
29.Feb.24 10:46 AM

Long COVID: Lingering Symptoms and Challenges for Patients

Since the confirmation of the first novel coronavirus infection in Japan in January 2020, many individuals continue to experience lingering symptoms of COVID-19, known as long COVID. Despite being classified under the same category as seasonal influenza since May 2023, the sense of urgency surrounding COVID-19 has lessened, making it challenging for individuals with ongoing symptoms to receive proper support and relief.
29.Feb.24 7:55 AM

Curadev Initiates Clinical Trial of Novel Cancer Immunotherapy

Curadev, a clinical-stage biotech company, has initiated a Phase 1a/b clinical trial to evaluate the safety and efficacy of CRD3874-SI, a novel systemic allosteric STING agonist, in patients with advanced sarcoma and Merkel cell carcinoma. The trial is being conducted at Memorial Sloan Kettering Cancer Center (MSKCC) in New York.
29.Feb.24 4:14 AM

Aboriginal Man's Death Raises Concerns About Healthcare Bias

An inquest is investigating the death of Ricky "Dougie" Hampson Jr., an Aboriginal man who died 24 hours after being discharged from Dubbo Base Hospital in New South Wales. The doctor who treated Mr. Hampson admitted to making an incorrect diagnosis, and the inquest will examine why scans were not performed and whether any biases influenced his treatment.
29.Feb.24 1:59 AM

A Potential Breakthrough for Multiple Food Allergies

Omalizumab, an injectable drug currently used for asthma, has shown promising results in reducing allergic reactions to food allergens in individuals with multiple food allergies. A study published in the New England Journal of Medicine found that omalizumab significantly decreased the severity of reactions to small amounts of allergens found in nuts, eggs, wheat, and milk.